Skip to main content
. 2017 Jun 26;17:447. doi: 10.1186/s12885-017-3413-3

Fig. 7.

Fig. 7

C1orf116 expression in cancer patient data. a Decreased expression of C1orf116 is seen in metastatic tumor type compared to primary prostate cancer (Taylor dataset); unadjusted P = 0.0340, Bonferroni adjusted P = 0.51. b Expression of C1orf116 decreases in high grade lung cancer (Director’s challenge dataset); Bonferroni adjusted P < 0.0005. c C1orf116 is downregulated in lung cancer patients with increased smoking habits (Director’s challenge dataset); unadjusted P < 0.01, Bonferroni adjusted P < 0.1. d C1orf116 is downregulated in lung cancer patients with smoking habits in comparison to non-smokers (Okayama dataset); unadjusted P = 0.0586, Bonferroni corrected P = 0.879